PRAX
insider transactionsPraxis Precision Medicines, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
13.4K sh
Own New
-
Grant·A
Director
$0
6.0K sh
Own +7%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +72%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +8%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +118%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +142%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +118%
-
Grant·A
Chief Operating Officer
$14.9K
89 sh · $167.94
Own +0%
-
Grant·A
Marcio Souza KEY
Chief Executive Officer
$21.2K
126 sh · $167.94
Own +0%
-
Grant·A
General Counsel and Secretary
$13.1K
78 sh · $167.94
Own +0%
-
Grant·A
Principal Accounting Officer
$21.3K
127 sh · $167.94
Own +1%
-
Grant·A
Chief Financial Officer
$20.3K
121 sh · $167.94
Own +0%
-
Other·D
Director
—
1.7K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
28.5K sh
Own -100%
-
Other·D
Director
—
4.7K sh
Own -100%
-
Other·D
Director
—
10.7K sh
Own -100%
-
Other·D
Director
—
45.0K sh
Own -100%
-
Other·D
Director
—
32.0K sh
Own -100%
-
Exercise·M
Director
$0
71.8K sh
Own New
-
Exercise·M
Director
—
71.8K sh
Own +55%
-
Grant·A
Director
$0
41.1K sh
Own New
-
Grant·A
Director
$0
35.6K sh
Own New
-
Grant·A
Director
$69.0K
19.7K sh · $3.51
Own +18%
-
Grant·A
Director
$0
224 sh
Own New
-
Grant·A
Director
$0
478 sh
Own +69%
-
Grant·A
Director
$0
688 sh
Own New
-
Grant·A
Director
$0
224 sh
Own New
-
Grant·A
Director
$0
478 sh
Own +69%
-
Grant·A
Director
$0
688 sh
Own New
-
Grant·A
Director
$0
1.7K sh
Own New
-
Other·F
Chief Operating Officer
$244.0K
885 sh · $275.74
Own -3%
-
Other·F
General Counsel and Secretary
$211.8K
768 sh · $275.74
Own -3%
-
Other·F
Principal Accounting Officer
$94.9K
344 sh · $275.74
Own -2%
-
Other·F
Chief Financial Officer
$260.0K
943 sh · $275.74
Own -3%
-
Other·F
Chief Operating Officer
$313.5K
1.1K sh · $288.45
Own -4%
-
Other·F
Marcio Souza KEY
Chief Executive Officer
$1.2M
4.3K sh · $288.45
Own -5%
-
Other·F
General Counsel and Secretary
$264.5K
917 sh · $288.45
Own -3%
-
Other·F
Principal Accounting Officer
$105.9K
367 sh · $288.45
Own -3%
-
Other·F
Chief Financial Officer
$385.1K
1.3K sh · $288.45
Own -4%
-
Grant·A
Chief Operating Officer
$0
7.7K sh
Own New
-
Grant·A
Chief Operating Officer
$0
9.6K sh
Own +46%
-
Grant·A
Marcio Souza KEY
Chief Executive Officer
$0
22.1K sh
Own New
-
Grant·A
Marcio Souza KEY
Chief Executive Officer
$0
27.6K sh
Own +52%
-
Grant·A
General Counsel and Secretary
$0
5.5K sh
Own New
-
Grant·A
General Counsel and Secretary
$0
6.9K sh
Own +33%
-
Grant·A
Principal Accounting Officer
$0
7.5K sh
Own New
-
Grant·A
Principal Accounting Officer
$0
3.8K sh
Own +36%
-
Grant·A
Chief Financial Officer
$0
7.0K sh
Own New
-
Grant·A
Chief Financial Officer
$0
8.8K sh
Own +36%
-
Other·F
Marcio Souza KEY
Chief Executive Officer
$118.5K
405 sh · $292.63
Own -1%
-
Other·F
General Counsel and Secretary
$26.0K
89 sh · $292.63
Own -0%
-
Other·F
Principal Accounting Officer
$10.2K
35 sh · $292.63
Own -0%
-
Other·F
Chief Financial Officer
$40.7K
139 sh · $292.63
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Dean J Mitchell | Grant A | 13.4K | $0 |
| Jun 12, 2026 | Dean J Mitchell | Grant A | 6.0K | $0 |
| Jun 10, 2026 | William D Young | Grant A | 648 | $0 |
| Jun 10, 2026 | William D Young | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Dean J Mitchell | Grant A | 648 | $0 |
| Jun 10, 2026 | Dean J Mitchell | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jeffrey B Kindler | Grant A | 648 | $0 |
| Jun 10, 2026 | Jeffrey B Kindler | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jill Desimone | Grant A | 648 | $0 |
| Jun 10, 2026 | Jill Desimone | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Merit Ester Cudkowicz | Grant A | 648 | $0 |
| Jun 10, 2026 | Merit Ester Cudkowicz | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jeffrey Chodakewitz | Grant A | 648 | $0 |
| Jun 10, 2026 | Jeffrey Chodakewitz | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Stuart A Arbuckle | Grant A | 648 | $0 |
| Jun 10, 2026 | Stuart A Arbuckle | Grant A | 1.4K | $0 |
| May 14, 2026 | Megan Sniecinski | Grant A | 89 | $14.9K |
| May 14, 2026 | Marcio Souza KEY | Grant A | 126 | $21.2K |
| May 14, 2026 | Alex Nemiroff | Grant A | 78 | $13.1K |
| May 14, 2026 | Lauren Mastrocola | Grant A | 127 | $21.3K |
| May 14, 2026 | Timothy Edwin Kelly KEY | Grant A | 121 | $20.3K |
| May 5, 2026 | Jeffrey B Kindler | Other D | 1.7K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 22.0K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 28.5K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 4.7K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 10.7K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 45.0K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 32.0K | — |
| Mar 13, 2026 | Jeffrey B Kindler | Exercise M | 71.8K | $0 |
| Mar 13, 2026 | Jeffrey B Kindler | Exercise M | 71.8K | — |
| Mar 10, 2026 | Jeffrey B Kindler | Grant A | 41.1K | $0 |
| Mar 10, 2026 | Jeffrey B Kindler | Grant A | 35.6K | $0 |
| Mar 10, 2026 | Jeffrey B Kindler | Grant A | 19.7K | $69.0K |
| Feb 6, 2026 | Jeffrey B Kindler | Grant A | 224 | $0 |
| Feb 6, 2026 | Jeffrey B Kindler | Grant A | 478 | $0 |
| Feb 6, 2026 | Jeffrey B Kindler | Grant A | 688 | $0 |
| Feb 6, 2026 | Stuart A Arbuckle | Grant A | 224 | $0 |
| Feb 6, 2026 | Stuart A Arbuckle | Grant A | 478 | $0 |
| Feb 6, 2026 | Stuart A Arbuckle | Grant A | 688 | $0 |
| Feb 1, 2026 | Jeffrey B Kindler | Grant A | 1.7K | $0 |
| Jan 12, 2026 | Megan Sniecinski | Other F | 885 | $244.0K |
| Jan 12, 2026 | Alex Nemiroff | Other F | 768 | $211.8K |
| Jan 12, 2026 | Lauren Mastrocola | Other F | 344 | $94.9K |
| Jan 12, 2026 | Timothy Edwin Kelly KEY | Other F | 943 | $260.0K |
| Jan 10, 2026 | Megan Sniecinski | Other F | 1.1K | $313.5K |
| Jan 10, 2026 | Marcio Souza KEY | Other F | 4.3K | $1.2M |
| Jan 10, 2026 | Alex Nemiroff | Other F | 917 | $264.5K |
| Jan 10, 2026 | Lauren Mastrocola | Other F | 367 | $105.9K |
| Jan 10, 2026 | Timothy Edwin Kelly KEY | Other F | 1.3K | $385.1K |
| Jan 8, 2026 | Megan Sniecinski | Grant A | 7.7K | $0 |
| Jan 8, 2026 | Megan Sniecinski | Grant A | 9.6K | $0 |
| Jan 8, 2026 | Marcio Souza KEY | Grant A | 22.1K | $0 |
| Jan 8, 2026 | Marcio Souza KEY | Grant A | 27.6K | $0 |
| Jan 8, 2026 | Alex Nemiroff | Grant A | 5.5K | $0 |
| Jan 8, 2026 | Alex Nemiroff | Grant A | 6.9K | $0 |
| Jan 8, 2026 | Lauren Mastrocola | Grant A | 7.5K | $0 |
| Jan 8, 2026 | Lauren Mastrocola | Grant A | 3.8K | $0 |
| Jan 8, 2026 | Timothy Edwin Kelly KEY | Grant A | 7.0K | $0 |
| Jan 8, 2026 | Timothy Edwin Kelly KEY | Grant A | 8.8K | $0 |
| Jan 7, 2026 | Marcio Souza KEY | Other F | 405 | $118.5K |
| Jan 7, 2026 | Alex Nemiroff | Other F | 89 | $26.0K |
| Jan 7, 2026 | Lauren Mastrocola | Other F | 35 | $10.2K |
| Jan 7, 2026 | Timothy Edwin Kelly KEY | Other F | 139 | $40.7K |
About PRAX insider trading
This page tracks insider transactions for Praxis Precision Medicines, Inc. (PRAX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.